Neoadjuvant Chemoradiation and Duration of Chemotherapy Before Surgical Resection for Pancreatic Cancer: Does Time Interval Between Radiotherapy and Surgery Matter?

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer

(2012) Daniel Habermehl et al.   Radiation Oncology

Optimal Timing of Surgery After Chemoradiation for Advanced Rectal Cancer

(2011) Julio Garcia-Aguilar et al.   ANNALS OF SURGERY

Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer

(2011) Yun Shin Chun et al.   ANNALS OF SURGICAL ONCOLOGY

Assessing Treatment Effect in Pancreatic Cancer

(2011) Douglas J Hartman et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma

(2011) Deyali Chatterjee et al.   CANCER

Borderline Resectable Pancreatic Cancer: Definitions and the Importance of Multimodality Therapy

(2010) Douglas B. Evans et al.   ANNALS OF SURGICAL ONCOLOGY

Defining Venous Involvement in Borderline Resectable Pancreatic Cancer

(2010) Yun Shin Chun et al.   ANNALS OF SURGICAL ONCOLOGY

Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement

(2009) Mark P. Callery et al.   ANNALS OF SURGICAL ONCOLOGY

Neoadjuvant Chemoradiation in Patients With Potentially Resectable Pancreatic Cancer

(2009) Soichiro Takai et al.   PANCREAS

Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic Head

(2008) Stefan Heinrich et al.   JOURNAL OF CLINICAL ONCOLOGY